We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RPM:NYSERPM International Inc. Analysis

Data as of 2026-08-30 - not real-time

$106.65

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

RPM International Inc. trades at $106.65, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it gained 1.5%. Momentum indicators put RSI at 42.6 (neutral) with MACD reading bearish. Recent trading has carved out support near $104.86 and resistance around $117.93.
On valuation the read is fair — an earnings multiple of 20.6, absent a reliable peer benchmark. Sell-side targets cluster 22.4% above the current quote. Revenue is growing at 7.2% on a 8.4% profit margin. The 2.04% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 33.8%, a beta of 0.94 and a maximum drawdown of 27.3%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.

Top Market Events

RPM International Inc RPM reports robust revenue growth, record adjusted EBIT, and strategic shareholder returns amidst...Seeking Alpha1monRPM International Inc. RPM Q4 2026 Earnings Call TranscriptGood day, everyone, and welcome to the RPM...ADVFN2monRPM Declares Quarterly DividendRPM International Inc.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 106.64
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 106.64
  • Analyst targets imply +22.4% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Analyst targets imply +22.4% versus the current price
  • P/E ratio of 20.6
  • Return on equity of 21.4%

Key Metrics & Analysis

Financial Health

Revenue Growth7.20%
Profit Margin8.41%
P/E Ratio20.6
ROE21.37%
ROA7.63%
Debt/Equity89.02
P/B Ratio4.1
Op. Cash Flow$898.7M
Free Cash Flow$480.1M

Technical Analysis

TrendBullish
RSI42.6
Support$104.86
Resistance$117.93
MA 20$111.85
MA 50$109.03
MA 200$106.64
MACDBearish
VolumeIncreasing
Fear & Greed Index95.66

Valuation

Fair Value$44.95
Target Price$130.50
Upside/Downside22.36%
GradeFair
TypeBlend
Dividend Yield2.04%

Risk Assessment

Beta0.94
Volatility33.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.